Cargando…

Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection

BACKGROUND: Paracoccidioidomycosis (PCM) is a neglected systemic mycosis caused by a dimorphic fungus of the Paracoccidioides genus. The standard diagnosis is based on isolation of the fungi in culture, and by microscopic visualization of characteristic multiple budding yeast cells in biological sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamikawa, Camila Mika, Mendes, Rinaldo Poncio, Vicentini, Adriana Pardini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312266/
https://www.ncbi.nlm.nih.gov/pubmed/28239394
http://dx.doi.org/10.1186/s40409-017-0101-3
_version_ 1782508171417354240
author Kamikawa, Camila Mika
Mendes, Rinaldo Poncio
Vicentini, Adriana Pardini
author_facet Kamikawa, Camila Mika
Mendes, Rinaldo Poncio
Vicentini, Adriana Pardini
author_sort Kamikawa, Camila Mika
collection PubMed
description BACKGROUND: Paracoccidioidomycosis (PCM) is a neglected systemic mycosis caused by a dimorphic fungus of the Paracoccidioides genus. The standard diagnosis is based on isolation of the fungi in culture, and by microscopic visualization of characteristic multiple budding yeast cells in biological samples. However, in some situations, access to the site of injury prevents the collection of biological material. A variety of immuno-serological techniques has proven useful for allowing inferring diagnosis with a certain degree of certainty, thus optimizing time. The aim of this study was to standardize and validate the Dot-ELISA (DE) assay, comparing it with the serological standard, double immunodiffusion (DI). METHODS: In order to standardize the DE assay, 143 serum samples were used. Out of those, 23 were from apparently healthy patients, 77 were from patients with confirmed PCM and 43 were from patients with other lung infections (tuberculosis, aspergillosis and histoplasmosis). To validate the DE technique, 300 serum samples from patients with PCM clinical suspicion (probable and possible cases) were employed, and these results were compared with those of DI. RESULTS: The DE assay showed sensitivity of 91%, specificity of 95.4%, positive predictive value of 96%, negative predictive value of 98.2%, accuracy of 93%, and great precision (k = 0.93). In addition, the nitrocellulose membranes have proved to be viable for using at least 90 days after P. brasiliensis B-339 antigen sensitization. CONCLUSION: Dot-ELISA method was found to be an extremely promising tool as serologic screening technique, because of its high sensitivity. Furthermore, Dot-ELISA shows the prospect of being transferred to laboratories of mycoserology including those with fewer resources or even to be used directly in the field. It has an excellent shelf life – membranes coated with antigen can be used for testing without changes in the pattern of reactivity among laboratories – and presents reliable values of sensitivity, specificity, predictive values, accuracy and a high correlation with the serological standard methodology. Based on the present findings, it possible to state that this technique constitutes a remarkable option to be used in routine diagnosis for public health centers.
format Online
Article
Text
id pubmed-5312266
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53122662017-02-24 Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection Kamikawa, Camila Mika Mendes, Rinaldo Poncio Vicentini, Adriana Pardini J Venom Anim Toxins Incl Trop Dis Research BACKGROUND: Paracoccidioidomycosis (PCM) is a neglected systemic mycosis caused by a dimorphic fungus of the Paracoccidioides genus. The standard diagnosis is based on isolation of the fungi in culture, and by microscopic visualization of characteristic multiple budding yeast cells in biological samples. However, in some situations, access to the site of injury prevents the collection of biological material. A variety of immuno-serological techniques has proven useful for allowing inferring diagnosis with a certain degree of certainty, thus optimizing time. The aim of this study was to standardize and validate the Dot-ELISA (DE) assay, comparing it with the serological standard, double immunodiffusion (DI). METHODS: In order to standardize the DE assay, 143 serum samples were used. Out of those, 23 were from apparently healthy patients, 77 were from patients with confirmed PCM and 43 were from patients with other lung infections (tuberculosis, aspergillosis and histoplasmosis). To validate the DE technique, 300 serum samples from patients with PCM clinical suspicion (probable and possible cases) were employed, and these results were compared with those of DI. RESULTS: The DE assay showed sensitivity of 91%, specificity of 95.4%, positive predictive value of 96%, negative predictive value of 98.2%, accuracy of 93%, and great precision (k = 0.93). In addition, the nitrocellulose membranes have proved to be viable for using at least 90 days after P. brasiliensis B-339 antigen sensitization. CONCLUSION: Dot-ELISA method was found to be an extremely promising tool as serologic screening technique, because of its high sensitivity. Furthermore, Dot-ELISA shows the prospect of being transferred to laboratories of mycoserology including those with fewer resources or even to be used directly in the field. It has an excellent shelf life – membranes coated with antigen can be used for testing without changes in the pattern of reactivity among laboratories – and presents reliable values of sensitivity, specificity, predictive values, accuracy and a high correlation with the serological standard methodology. Based on the present findings, it possible to state that this technique constitutes a remarkable option to be used in routine diagnosis for public health centers. BioMed Central 2017-02-15 /pmc/articles/PMC5312266/ /pubmed/28239394 http://dx.doi.org/10.1186/s40409-017-0101-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kamikawa, Camila Mika
Mendes, Rinaldo Poncio
Vicentini, Adriana Pardini
Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection
title Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection
title_full Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection
title_fullStr Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection
title_full_unstemmed Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection
title_short Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection
title_sort standardization and validation of dot-elisa assay for paracoccidioides brasiliensis antibody detection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312266/
https://www.ncbi.nlm.nih.gov/pubmed/28239394
http://dx.doi.org/10.1186/s40409-017-0101-3
work_keys_str_mv AT kamikawacamilamika standardizationandvalidationofdotelisaassayforparacoccidioidesbrasiliensisantibodydetection
AT mendesrinaldoponcio standardizationandvalidationofdotelisaassayforparacoccidioidesbrasiliensisantibodydetection
AT vicentiniadrianapardini standardizationandvalidationofdotelisaassayforparacoccidioidesbrasiliensisantibodydetection